FDA Inspection 1288392 — Angel Rivero Calaf
The FDA completed an inspection of Angel Rivero Calaf on October 17, 2025 in Barcelona. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 17, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Barcelona (Spain)
Additional Details
Clinical Investigator (CI)